USP38, or Ubiquitin-Specific Protease 38, is a member of the ubiquitin-specific protease family of enzymes encoded by the USP38 gene in humans. This enzyme plays a critical role in the ubiquitin-proteasome system, a vital cellular pathway responsible for degrading and recycling proteins. The ubiquitin-proteasome system maintains cellular homeostasis by regulating protein levels, thereby controlling numerous cellular processes such as cell cycle progression, DNA repair, and signal transduction.
As a deubiquitinating enzyme (DUB), USP38 specifically removes ubiquitin molecules from target proteins. Ubiquitination, the process of attaching ubiquitin to a protein, typically marks the protein for degradation by the proteasome. However, deubiquitination by USP38 reverses this process, rescuing proteins from degradation. This action of USP38 is crucial for regulating the stability and function of its target proteins, thereby influencing various cellular pathways.USP38 is involved in multiple cellular processes, including stress responses, immune signaling, and apoptosis. Its activity can impact the regulation of key signaling pathways, contributing to the fine-tuning of cellular responses to external stimuli and internal cues. Due to its role in these critical pathways, dysregulation of USP38 has been implicated in various diseases, including cancer, neurodegenerative disorders, and immune-related conditions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 is a proteasome inhibitor that can affect ubiquitin-dependent protein degradation, potentially influencing USP38 activity indirectly. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib, another proteasome inhibitor, could indirectly impact USP38 by altering ubiquitin-mediated protein turnover. | ||||||
Carfilzomib | 868540-17-4 | sc-396755 | 5 mg | $41.00 | ||
As a selective proteasome inhibitor, Carfilzomib could indirectly influence USP38 activity by impacting protein degradation pathways. | ||||||
Stat3 Inhibitor III, WP1066 | 857064-38-1 | sc-203282 | 10 mg | $132.00 | 72 | |
WP1130, a deubiquitinase inhibitor, might indirectly modulate USP38 activity by influencing the ubiquitin-proteasome system. | ||||||
NSC697923 | 343351-67-7 | sc-391107 sc-391107A | 1 mg 5 mg | $15.00 $52.00 | 3 | |
NSC697923 targets the Ubc13-Uev1A E2 complex, which is part of the ubiquitin-conjugating system, potentially affecting USP38. | ||||||